Peer Reviewed
Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Natalie Rosario, PharmD, MPH, BCACP
Advertisement
Articles by Natalie Rosario, PharmD, MPH, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
3
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
4
New CKD Outcome Set Tells Pharmacists What to Measure
5